Thank you to the Nucleate Boston Activator Program for selecting Neoclease as the recipient of the Alnylam Pharmaceuticals Regional Scientific Excellence Award. We are honored to be chosen among so many incredible new startups. At Neoclease, we merge cutting-edge scientific research with advanced AI technology to bring precision gene editing forward. Thank you for recognizing our commitment to innovation and scientific excellence! Our team will be at BIO in San Diego and we would love to meet with you! Reach out to us here or at info@neoclease.com to say hello. #NucleateActivator #AlnylamPharmaceuticals #ScientificExcellence #neoclease #PrecisionMedicine #GeneEditing #Innovation #AI
Neoclease
Biotechnology Research
Boston , Massachusetts 100 followers
Neoclease is leading the charge toward a future where gene editing becomes the cornerstone of precision medicine.
About us
At Neoclease, we're pushing the frontiers of gene editing and synthetic biology, unlocking new features, domains, and potentialities. With over 6,000 monogenic diseases in existence, we refuse to rely on a one-size-fits-all approach. Instead, we're developing bespoke nucleases, tailored gene editors, each designed to combat a specific disease or gene of interest. Our mission is to revolutionize the landscape of healthcare by building more precise, efficient, and targeted gene editors. Through relentless innovation, advanced technology, and unwavering dedication, we're leading the charge toward a future where gene editing becomes the cornerstone of precision medicine. Our technology is more than just a tool; it's the key to unlocking a future where genetic diseases are a thing of the past.
- Website
-
https://www.neoclease.ai/
External link for Neoclease
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Boston , Massachusetts
- Type
- Privately Held
- Founded
- 2023
Locations
-
Primary
Get directions
Boston , Massachusetts , US